Aceragen, a biopharmaceutical company specializing in the development of treatments for rare genetic conditions, recently shared their novel approach to mapping Farber disease prevalence at ASHG 2022. Using VarSome Insights, the team were able to...
Aceragen Maps Rare Disease Prevalence with VarSome Insights
By
Xanthippi Papakonstanti on March 2, 2023
0
0